TATA HEALTH (01255) announced that on September 4, 2025, the company received a letter from the Hong Kong Stock Exchange setting out additional guidance for the resumption of trading of the shares on the Stock Exchange (the "Additional Resumption Guidance", together with the Initial Resumption Guidance, collectively the "Resumption Guidance"):
Re-compliance with Rule 3.10(2) of the Listing Rules.
Additionally, the company's shares continue to be suspended from trading.